Cooper Companies (COO) Other Non-Current Assets (2009 - 2026)
Cooper Companies' (COO) quarterly Other Non-Current Assets came in at $672.8 million in Q2 2026, up 2.09% year-on-year from $659.0 million in Q2 2025, and down 2.27% quarter-over-quarter from $688.4 million in Q1 2026.
Cooper Companies (COO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Cooper Companies' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $672.8 million for Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 2.09% year-over-year to $672.8 million in Q2 2026; TTM through Apr 2026 was $672.8 million, a 2.09% increase from a year earlier, with the FY2025 full-year figure at $689.2 million, up 4.33% from the prior year.
- Other Non-Current Assets slipped to $672.8 million in Q2 2026 per COO's latest filing, from $688.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $689.2 million in Q4 2025 and bottomed at $106.8 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $632.6 million (2023), against an average of $572.2 million.
- Across the five-year window, Other Non-Current Assets soared 432.58% in 2023 and decreased 1.08% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $587.9 million in 2022, then gained by 8.37% to $637.1 million in 2023, then gained by 3.69% to $660.6 million in 2024, then increased by 4.33% to $689.2 million in 2025, then declined by 2.38% to $672.8 million in 2026.
- Per Business Quant, the three latest COO Other Non-Current Assets figures stand at $672.8 million (Q2 2026), $688.4 million (Q1 2026), and $689.2 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 692.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 672.80 Mn |
| Jan 31, 2026 | 688.40 Mn |
| Oct 31, 2025 | 689.20 Mn |
| Jul 31, 2025 | 653.30 Mn |
| Apr 30, 2025 | 659.00 Mn |
| Jan 31, 2025 | 663.70 Mn |
| Oct 31, 2024 | 660.60 Mn |
| Jul 31, 2024 | 621.40 Mn |
| Apr 30, 2024 | 637.20 Mn |
| Jan 31, 2024 | 616.90 Mn |
| Oct 31, 2023 | 637.10 Mn |
| Jul 31, 2023 | 628.20 Mn |
| Apr 30, 2023 | 584.80 Mn |
| Jan 31, 2023 | 568.80 Mn |
| Oct 31, 2022 | 587.90 Mn |
| Jul 31, 2022 | 306.00 Mn |
| Apr 30, 2022 | 317.40 Mn |
| Jan 31, 2022 | 106.80 Mn |
| Oct 31, 2021 | 401.20 Mn |
| Jul 31, 2021 | 88.10 Mn |